Abnormal expression of FOSB correlates with tumor progression and poor survival in patients with gastric cancer

Tang,Chong; Jiang,Yasu; Shao,Weiwei; Shi,Wen; Gao,Xuesong; Qin,Weiyan; Jiang,Tian; Wang,Feiran; Feng,Shichun

doi:10.3892/ijo.2016.3661

Abnormal expression of FOSB correlates with tumor progression and poor survival in patients with gastric cancer

Authors:
- Chong Tang
- Yasu Jiang
- Weiwei Shao
- Wen Shi
- Xuesong Gao
- Weiyan Qin
- Tian Jiang
- Feiran Wang
- Shichun Feng
View Affiliations

Affiliations: Department of General Surgery, The Second Affiliated Hospital of Nantong University, Nantong University, Nantong, Jiangsu 226001, P.R. China, Department of General Surgery, The Fourth Affiliated Hospital of Nantong University, Nantong University, Yancheng, Jiangsu 224000, P.R. China, Department of General Surgery, The Affiliated Hospital of Nantong University, Nantong University, Nantong, Jiangsu 226001, P.R. China
Published online on: August 18, 2016 https://doi.org/10.3892/ijo.2016.3661
Pages: 1489-1496

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

FOSB protein is encoded by the FOSB gene in humans, which shares structural similarities with the prototype of the Fos family. FOSB plays a role by AP-1 complex which is composed of heterodimers of Jun and Fos members. Our experiment aimed to evaluate the effect of FOSB in gastric cancer (GC) patients and then probe its significance in prognosis. We detected the expression of FOSB in GC and adjacent non-cancerous tissues by western blot analysis and real-time quantitative PCR (qRT-PCR). Moreover, we analyzed FOSB expression in patients who underwent resection procedures using immunohistochemistry. The relationship between the expression of FOSB, the clinicopathological characteristics and the patients survival were also investigated. Furthermore, in vitro, we evaluated the effects of FOSB gene on gastric cancer cell viability, proliferation and migration by MTT, clone formation and transwell assays. Finally, the Kaplan-Meier method and log-rank test were used to compare the overall survival between high FOSB expression group and low FOSB expression group. Immunohistochemical staining data showed that FOSB expression was significantly decreased in gastric cancer cases. In addition, we confirmed FOSB downregulation in both mRNA and protein levels in GC tissues compared with matched adjacent non-cancerous tissues. Downregulated expression of FOSB was correlated with poor differentiation, lymph node metastasis and advanced TNM stage. Moreover, we found that low FOSB expression exhibited a significant correlation with poor prognosis for GC patients by Kaplan-Meier survival analysis. Overexpression of FOSB significantly suppressed cell proliferation, clone formation and migration in GC cell lines. In contrast, silencing of FOSB expression in GC cells promoted proliferation, clone formation and migration. Our results showed that FOSB plays a crucial role in the suppression of GC, and that it may be a useful biomarker in diagnosis and prognosis for GC patients.

View Figures

View References

1	Ajani JA, Bentrem DJ, Besh S, D’Amico TA, Das P, Denlinger C, Fakih MG, Fuchs CS, Gerdes H, Glasgow RE, et al; National Comprehensive Cancer Network. Gastric cancer, version 2.2013: Featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 11:531–546. 2013.PubMed/NCBI
2	Lin Y, Ueda J, Kikuchi S, Totsuka Y, Wei WQ, Qiao YL and Inoue M: Comparative epidemiology of gastric cancer between Japan and China. World J Gastroenterol. 17:4421–4428. 2011. View Article : Google Scholar : PubMed/NCBI
3	Howlett M, Menheniott TR, Judd LM and Giraud AS: Cytokine signalling via gp130 in gastric cancer. Biochim Biophys Acta. 1793:1623–1633. 2009. View Article : Google Scholar : PubMed/NCBI
4	Siderovski DP, Blum S, Forsdyke RE and Forsdyke DR: A set of human putative lymphocyte G₀/G₁ switch genes includes genes homologous to rodent cytokine and zinc finger protein-encoding genes. DNA Cell Biol. 9:579–587. 1990. View Article : Google Scholar : PubMed/NCBI
5	Martin-Gallardo A, McCombie WR, Gocayne JD, FitzGerald MG, Wallace S, Lee BM, Lamerdin J, Trapp S, Kelley JM, Liu LI, et al: Automated DNA sequencing and analysis of 106 kilobases from human chromosome 19q13.3. Nat Genet. 1:34–39. 1992. View Article : Google Scholar : PubMed/NCBI
6	Zerial M, Toschi L, Ryseck RP, Schuermann M, Müller R and Bravo R: The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. EMBO J. 8:805–813. 1989.PubMed/NCBI
7	Hess J, Angel P and Schorpp-Kistner M: AP-1 subunits: Quarrel and harmony among siblings. J Cell Sci. 117:5965–5973. 2004. View Article : Google Scholar : PubMed/NCBI
8	Krosl J and Sauvageau G: AP-1 complex is effector of Hox-induced cellular proliferation and transformation. Oncogene. 19:5134–5141. 2000. View Article : Google Scholar : PubMed/NCBI
9	Mechta F, Lallemand D, Pfarr CM and Yaniv M: Transformation by ras modifies AP1 composition and activity. Oncogene. 14:837–847. 1997. View Article : Google Scholar : PubMed/NCBI
10	Pospelova TV, Medvedev AV, Kukushkin AN, Svetlikova SB, van der Eb AJ, Dorsman JC and Pospelov VA: E1A + cHa-ras transformed rat embryo fibroblast cells are characterized by high and constitutive DNA binding activities of AP-1 dimers with significantly altered composition. Gene Expr. 8:19–32. 1999.PubMed/NCBI
11	Chung JY, Huang C, Meng X, Dong Z and Yang CS: Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: Structure-activity relationship and mechanisms involved. Cancer Res. 59:4610–4617. 1999.PubMed/NCBI
12	Darne C, Martinez A, Lallemand D, Morel L, Jean C, Saru JP, Schmid HP and Manin M: Down-regulation of AP1 activities after polarization of vas deferens epithelial cells correlates with androgen-induced gene expression. J Steroid Biochem Mol Biol. 72:103–113. 2000. View Article : Google Scholar : PubMed/NCBI
13	Ng DC, Shafaee S, Lee D and Bikle DD: Requirement of an AP-1 site in the calcium response region of the involucrin promoter. J Biol Chem. 275:24080–24088. 2000. View Article : Google Scholar : PubMed/NCBI
14	Milde-Langosch K, Kappes H, Riethdorf S, Löning T and Bamberger AM: FosB is highly expressed in normal mammary epithelia, but down-regulated in poorly differentiated breast carcinomas. Breast Cancer Res Treat. 77:265–275. 2003. View Article : Google Scholar : PubMed/NCBI
15	Kim JH, Lee JY, Lee KT, Lee JK, Lee KH, Jang KT, Heo JS, Choi SH and Rhee JC: RGS16 and FosB underexpressed in pancreatic cancer with lymph node metastasis promote tumor progression. Tumour Biol. 31:541–548. 2010. View Article : Google Scholar : PubMed/NCBI
16	Wang J, Yu JC, Kang WM and Ma ZQ: Treatment strategy for early gastric cancer. Surg Oncol. 21:119–123. 2012. View Article : Google Scholar
17	Mahar AL, Coburn NG, Singh S, Law C and Helyer LK: A systematic review of surgery for non-curative gastric cancer. Gastric Cancer. 15(Suppl 1): S125–S137. 2012. View Article : Google Scholar
18	Piazuelo MB and Correa P: Gastric cáncer: Overview. Colomb Med (Cali). 44:192–201. 2013.
19	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
20	van Seventer GA, Salmen HJ, Law SF, O’Neill GM, Mullen MM, Franz AM, Kanner SB, Golemis EA and van Seventer JM: Focal adhesion kinase regulates beta1 integrin-dependent T cell migration through an HEF1 effector pathway. Eur J Immunol. 31:1417–1427. 2001. View Article : Google Scholar : PubMed/NCBI
21	Milde-Langosch K: The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer. 41:2449–2461. 2005. View Article : Google Scholar : PubMed/NCBI
22	Ryseck RP and Bravo R: c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: Effect of FOS proteins. Oncogene. 6:533–542. 1991.PubMed/NCBI
23	Yamaoka Y, Kato M and Asaka M: Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med. 47:1077–1083. 2008. View Article : Google Scholar : PubMed/NCBI
24	Wang F, Sun GP, Zou YF, Zhong F, Ma T, Li XQ and Wu D: Helicobacter pylori infection predicts favorable outcome in patients with gastric cancer. Curr Oncol. 20:e388–e395. 2013. View Article : Google Scholar : PubMed/NCBI
25	Lucibello FC, Slater EP, Jooss KU, Beato M and Müller R: Mutual transrepression of Fos and the glucocorticoid receptor: Involvement of a functional domain in Fos which is absent in FosB. EMBO J. 9:2827–2834. 1990.PubMed/NCBI
26	Angel P and Karin M: The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1072:129–157. 1991.PubMed/NCBI
27	Rosen JM, Zahnow C, Kazansky A and Raught B: Composite response elements mediate hormonal and developmental regulation of milk protein gene expression. Biochem Soc Symp. 63:101–113. 1998.PubMed/NCBI